News Recap: Micron Technology, Yahoo! Inc, VIVUS, Arena Pharmaceuticals

NEW YORK, March 04, 2013 - vb-news.net, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Micron Technology, Yahoo! Inc, VIVUS, Arena Pharmaceuticals.

Micron Technology, Inc. (NASDAQ:MU - News) has said that the Tokyo district court has issued an order approving its acquisition of Japanese memory chipmaker Elpida after creditors agreed to the plan.

Is MU a Buy After The Recent Slump? Lets find Out Here http://vbtrendreport.com/aw/?code=MU

In July, the Idaho company offered to buy Elpida for about $750 million in cash and to pay creditors a total of $1.75 billion in annual installments through 2019. Micron is losing money as the PC industry is in shambles and wants to gain larger economies of scale which is possible with this acquisition.

A group of bondholders led by hedge funds Linden Advisors, Owl Creek Asset Management and Taconic Capital Advisors have also been interested in the company for some time and they have filed a suit at the U.S. Bankruptcy Court in Delaware. Micron and Elpida now need approval from this court.

Elpida was driven into bankruptcy due to falling chip sales and foreign competition. The acquisition would make Micron the No. 2 global supplier of DRAM chips.

Meanwhile, Yahoo! Inc.(NASDAQ:YHOO - News) CEO Marissa Mayer is very much in the news of late thanks to her new rule that says all employees have to work from office; no more work-from-home.

Will YHOO Continue To Hit New Highs? Find out Here http://vbtrendreport.com/aw/?code=YHOO

This has drawn a lot of flak from all the work-from home folk who defend themselves saying that working from home does not hinder efficiency in any way, helps them save time on unnecessary commuting and helps achieve a better work-life balance.

The women who often have to bear household and children-related responsibilities will be affected the most. Many Yahoo work-from-home female employees may be feeling that Mayer expects all of them to live up to her formidable standards- her two-week maternity leave speaks volumes.

Read the original post:
News Recap: Micron Technology, Yahoo! Inc, VIVUS, Arena Pharmaceuticals